BACKGROUND AND OBJECTIVES: β-trace protein (βTP), β2-microglobulin (β2M), and cystatin C (CysC) have advantages over creatinine for estimating GFR and prognosis. This study compares the distribution of all four markers in the general population and their associations with possible determinants of GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: βTP and β2M were measured in 7596 participants (aged ≥12 years) of the Third National Health and Nutrition Examination Survey (1988-1994). βTP and β2M concentrations and the proportion of persons with elevated (≥99th percentile for young healthy participants) βTP (≥0.81 mg/L), β2M (≥2.80 mg/L), standardized CysC (≥1.03 mg/L), and creatinine (≥1.2 mg/dl for men and ≥1.0 mg/dl for women) were compared across demographic and clinical factors. RESULTS: Elevated βTP, β2M, and CysC showed stronger associations with age than elevated serum creatinine, the prevalence of elevated levels reaching 47%, 44%, 58%, and 26%, respectively, by age 80 years. βTP, CysC, and creatinine were higher in men but β2M was not associated with sex. Mexican Americans had lower βTP, β2M, CysC, and creatinine compared with non-Hispanic whites. Hypertension and higher C-reactive protein were associated with elevations in all markers, whereas non-Hispanic black race, body mass index, diabetes, smoking status, triglycerides, HDL cholesterol, and education were not associated in a consistent manner across the different markers. CONCLUSIONS: βTP, β2M, CysC, and creatinine differ in their associations with demographic and clinical factors, suggesting variation in their non-GFR determinants. Future studies should examine these markers with measured GFR to determine their diagnostic and prognostic utility.
BACKGROUND AND OBJECTIVES: β-trace protein (βTP), β2-microglobulin (β2M), and cystatin C (CysC) have advantages over creatinine for estimating GFR and prognosis. This study compares the distribution of all four markers in the general population and their associations with possible determinants of GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: βTP and β2M were measured in 7596 participants (aged ≥12 years) of the Third National Health and Nutrition Examination Survey (1988-1994). βTP and β2M concentrations and the proportion of persons with elevated (≥99th percentile for young healthy participants) βTP (≥0.81 mg/L), β2M (≥2.80 mg/L), standardized CysC (≥1.03 mg/L), and creatinine (≥1.2 mg/dl for men and ≥1.0 mg/dl for women) were compared across demographic and clinical factors. RESULTS: Elevated βTP, β2M, and CysC showed stronger associations with age than elevated serum creatinine, the prevalence of elevated levels reaching 47%, 44%, 58%, and 26%, respectively, by age 80 years. βTP, CysC, and creatinine were higher in men but β2M was not associated with sex. Mexican Americans had lower βTP, β2M, CysC, and creatinine compared with non-Hispanic whites. Hypertension and higher C-reactive protein were associated with elevations in all markers, whereas non-Hispanic black race, body mass index, diabetes, smoking status, triglycerides, HDL cholesterol, and education were not associated in a consistent manner across the different markers. CONCLUSIONS: βTP, β2M, CysC, and creatinine differ in their associations with demographic and clinical factors, suggesting variation in their non-GFR determinants. Future studies should examine these markers with measured GFR to determine their diagnostic and prognostic utility.
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Elizabeth Selvin; Stephen P Juraschek; John Eckfeldt; Andrew S Levey; Lesley A Inker; Josef Coresh Journal: Am J Kidney Dis Date: 2013-01-20 Impact factor: 8.860
Authors: S Apakkan Aksun; D Ozmen; B Ozmen; Z Parildar; I Mutaf; N Turgan; S Habif; K Kumanlioğluc; O Bayindir Journal: Exp Clin Endocrinol Diabetes Date: 2004-04 Impact factor: 2.949
Authors: Anna E Prizment; Amy M Linabery; Pamela L Lutsey; Elizabeth Selvin; Heather H Nelson; Aaron R Folsom; Timothy R Church; Charles G Drake; Elizabeth A Platz; Corinne Joshu Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-02-05 Impact factor: 4.254
Authors: Tilman Schneider-Hohendorf; Dennis Görlich; Paula Savola; Tiina Kelkka; Satu Mustjoki; Catharina C Gross; Geoffrey C Owens; Luisa Klotz; Klaus Dornmair; Heinz Wiendl; Nicholas Schwab Journal: Proc Natl Acad Sci U S A Date: 2018-02-12 Impact factor: 11.205
Authors: Casey M Rebholz; Morgan E Grams; Kunihiro Matsushita; Elizabeth Selvin; Josef Coresh Journal: Am J Kidney Dis Date: 2014-12-24 Impact factor: 8.860
Authors: Xun Liu; Meredith C Foster; Hocine Tighiouart; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Josef Coresh; John H Eckfeldt; Harold I Feldman; Tom Greene; L Lee Hamm; Jiang He; Edward Horwitz; Julia Lewis; Ana C Ricardo; Haochang Shou; Raymond R Townsend; Matthew R Weir; Lesley A Inker; Andrew S Levey Journal: Am J Kidney Dis Date: 2016-09-20 Impact factor: 8.860
Authors: Lesley A Inker; Hocine Tighiouart; Josef Coresh; Meredith C Foster; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Tom Greene; Amy B Karger; John W Kusek; James Lash; Julia Lewis; Jeffrey R Schelling; Sankar D Navaneethan; James Sondheimer; Tariq Shafi; Andrew S Levey Journal: Am J Kidney Dis Date: 2015-09-09 Impact factor: 8.860
Authors: Meredith C Foster; Josef Coresh; Chi-Yuan Hsu; Dawei Xie; Andrew S Levey; Robert G Nelson; John H Eckfeldt; Ramachandran S Vasan; Paul L Kimmel; Jeffrey Schelling; Michael Simonson; James H Sondheimer; Amanda Hyre Anderson; Sanjeev Akkina; Harold I Feldman; John W Kusek; Akinlolu O Ojo; Lesley A Inker Journal: Am J Kidney Dis Date: 2016-03-03 Impact factor: 8.860
Authors: Chao Yang; Lucia Kwak; Shoshana H Ballew; Pranav S Garimella; Bernard G Jaar; Aaron R Folsom; Gerardo Heiss; Elizabeth Selvin; Pamela L Lutsey; Josef Coresh; Kunihiro Matsushita Journal: Atherosclerosis Date: 2017-09-22 Impact factor: 5.162
Authors: Meredith C Foster; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; John Eckfeldt; Stephen P Juraschek; Josef Coresh Journal: Am J Kidney Dis Date: 2013-03-19 Impact factor: 8.860